Market cap
₹2 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
--
P/B Ratio
1.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -3.59 | 384.00 | -84.26 | -64.20 | -33.86 |
| EBIT | 60.00 | 140.00 | 99.30 | -130.21 | 13.99 |
| Net Profit | 60.00 | 140.00 | 99.30 | -130.12 | -35.14 |
| EPS | 56.25 | -- | -868.59 | -130.11 | 2.61 |
| Book Value | -- | -- | -96.86 | -- | -45.24 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-13 | Mar-12 |
| EBIT-Margin
| -- | -- | -- | -197.92 | 21.28 |
| Net Margin
| -- | -- | -- | -- | 16.96 |
| Return on equity
| -- | -- | -- | -187.84 | 13.45 |
| Return on Capital
| -- | -- | -- | -187.83 | 16.96 |
| Return on Assets
| -- | -- | -- | -188.87 | 13.91 |
| Debt to Equity (x)
| -- | -- | -- | 0.00 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-187.83
|
16.96
|
17.92
|
0.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-187.84
|
13.45
|
19.51
|
0.60
|
|
Peer Median
|
3.56
|
--
|
--
|
--
|
--
|
ROA
--
--
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-188.87
|
13.91
|
20.98
|
0.16
|
|
Peer Median
|
0.98
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-197.92
|
21.28
|
18.61
|
-3.38
|
|
Peer Median
|
7.69
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-197.92
|
16.96
|
20.81
|
1.17
|
|
Peer Median
|
4.52
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-176.21
|
17.14
|
21.23
|
2.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-34.06
|
36.60
|
287.61
|
7.00
|
|
Peer Median
|
4.01
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-713.36
|
56.20
|
--
|
55.17
|
|
Peer Median
|
-2.34
|
--
|
--
|
--
|
--
|
Net Profit Growth
99.30
Higher than Peers by 99.85
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
99.30
|
-868.59
|
10.79
|
6,430.15
|
-69.89
|
|
Peer Median
|
-0.55
|
--
|
--
|
--
|
--
|
EPS Growth
--
--
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-868.59
|
10.79
|
2,889.88
|
-69.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
-96.86
|
14.42
|
199.03
|
0.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.14
|
--
|
--
|
--
|
--
|
Current Ratio
--
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
1.30
|
265.58
|
237.89
|
292.37
|
|
Peer Median
|
1.42
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
0.36
|
164.53
|
184.68
|
105.80
|
|
Peer Median
|
1.15
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
--
|
3,204.49
|
5,461.50
|
1.85
|
|
Peer Median
|
1.77
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
--
|
22.62
|
24.17
|
12.71
|
|
Peer Median
|
26.87
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
0.95
|
0.82
|
1.00
|
0.13
|
|
Peer Median
|
0.30
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
--
|
73.58
|
50.10
|
40.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
63.94
|
49.43
|
68.86
|
398.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
5.60
|
0.72
|
0.43
|
0.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
58.34
|
122.29
|
118.53
|
439.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
--
|
3.11
|
3.19
|
42.43
|
|
Peer Median
|
419.92
|
--
|
--
|
--
|
--
|
Price / Book Value
1.10
Lower than Peers by 1.14
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
1.10
|
2.96
|
0.39
|
0.42
|
0.25
|
|
Peer Median
|
2.24
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-13.27
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
-13.27
|
-0.11
|
2.44
|
3.40
|
12.81
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
2
Lower than Peers by 239
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-13
|
Mar-12
|
Mar-11
|
Mar-09
|
|---|---|---|---|---|---|
|
Socrus Bio Sciences
|
2
|
4
|
16
|
15
|
3
|
|
Peer Median
|
241
|
--
|
--
|
--
|
--
|